Nutriband Equity Warrant Exp 30th Sep 2026 NTRBW:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
4.00UNCH (UNCH)
Volume
1,458
52 week range
0.85 - 9.07
Loading...
  • Open3.98
  • Day High4.15
  • Day Low3.98
  • Prev Close4.00
  • 52 Week High9.07
  • 52 Week High Date03/30/22
  • 52 Week Low0.85
  • 52 Week Low Date10/01/21

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open3.98
  • Day High4.15
  • Day Low3.98
  • Prev Close4.00
  • 52 Week High9.07
  • 52 Week High Date03/30/22
  • 52 Week Low0.85
  • 52 Week Low Date10/01/21
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nutriband Equity Warrant Exp 30th Sep 2026

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. The Company's lead product is its AVERSA technology, an abuse deterrent technology that can be incorporated into any transdermal patch to deter the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. Its first product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an existing generic fentanyl patch...
Serguei Melnik
Chairman of the Board, President, Company Secretary
Gareth Sheridan
Chief Executive Officer, Director
Alan Smith Ph.D.
Chief Operating Officer, President - 4P Therapeutics
Gerald Goodman
Chief Financial Officer, Chief Accounting Officer
Patrick Ryan
Chief Technical Officer
Address
121 S Orange Ave Ste 1500
Orlando, FL
32801-3241
United States